CALM-2
Who is this for?
Those with refractory or unexplained chronic cough (cough ≥ 8 weeks)
Study:
This study looks at the drug BLU-5937. It aims to assess its safety and effectiveness at reducing cough.
Those with refractory or unexplained chronic cough (cough ≥ 8 weeks)
This study looks at the drug BLU-5937. It aims to assess its safety and effectiveness at reducing cough.